Another Green Rush for Marijuana Stocks?

Big Time Options Success Persists

The title of our report that we sent out on Friday morning was “Another Dream Week of Options Trading”, wherein we patted ourselves on the back for connecting on some serious options gainers every day of the week.

We would continue that trend with Friday’s fresh options ideas, offering up four separate ideas and hitting big on each and every one of them. Take a look at the incredible single session gains that were available to ourselves and anyone who caught our premarket report. Out of all four of our highlighted target ranges, multibag gains were there for the taking regardless of the chosen strike price.

SQ Weekly $177.50-185 Calls 
$177.50: 6.07-23.60 (+289%)
$180: 4.08-20.77 (+409%)
$182.50: 2.53-17.94 (+609%)
$185: 1.59-16.05 (+909%)
_____

CVS Weekly $62-63 Calls
$62: .98-5.30 (+441%)
$62.50: .77-4.70 (+510%)
$63: .55-4.30 (+681%)
_____

Two of our options plays from Friday were high profile marijuana-related stocks, a sector that we have a high interest in, and in addition to logging massive gains on the options front, the stocks themselves also outperformed many others on on the day and into the premarket this morning.  TLRY has run from 8.45-14.36 while CGC increased from 21.90 to 27.25. Those moves made the following gains possible for our designated options targets: 

CGC Weekly $21-21.50 Calls
$21: .92-4.00 (+335%)
$21.50: .70-3.40 (+386%)
_____

TLRY Weekly $7.50-8.50 Calls
$7.50: 1.00-4.43 (+343%)
$8: .44-4.00 (+809%)
$8.50: .31-3.50 (+1029%)

It appears we are witnessing a revitalization of the cannabis sector, which we have long been touting as a favorite market space of ours. Since the first Green Rush in 2012, we have been extremely interested in the marijuana industry and we could be on the verge of another big green wave of success! For that reason, we will dedicate our entire extended watchlist to cannabis plays today.


Fresh Options Ideas: 
MCD Weekly $225-230 Calls
PLUG Weekly $18.50-20 Calls 


Cannabis Watchlist:
ACB, APAH, SNDL, MJNA, PHOT, TRTC, ERBB, GRNH, CBDS, CNBX, NIUGS, MSRT, HEMP, WDRP

Blue Horseshoe Stocks: Pot Stocks Heating Up Again

Pot Stocks Still Heating Up

We have literally never stopped pounding the table on our interest in marijuana related stocks for more than five years now. While we cover something in the space practically every day, occasionally we sense a greater trend coming for the sector as a whole and issue reminders to our readers accordingly. The last such post, we published on November 9th, reminding our audience that we expected a resurgence heading into 2018, which figures to be a huge year for cannabis based business in general.

We gave a list of a handful of the symbols we routinely track which included MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, and CBIS.

GRNH and CBIS are have always been two of our favorites, although as we said, the sector as a whole will continue to be a major point of focus for us going forward. GRNH. since November 7th, has trended up from a low of .0341 to a high of .072; an increase of 111% Meanwhile, CBIS, in the same span has run from .0311 to .11, for a big 254% rise.

Some of the other fantastic moves to come out of that watchlist are as follows:

MJTK – .0005-.0028 – 460%
APHQF – 6.14-13.75 – 124%
AGTK – .0099-.0415 – 319%
ACBFF – 2.77-6.86 – 148%

These are just to name a few. Our docket of cannabis plays that we follow regularly is far too large to update all in one report, but once again, we’re going to be placing a high amount of focus on everything pot related heading into and throughout 2018.


Applied DNA Sciences, Inc. APDN

We also would like to highlight APDN, a stock that has an interesting bottom setup on the chart. As you can see on the included snapshot, the PPS has been beaten back to its lowest levels since this summer, and are hovering around a solid support level.

Couple that with the company being slated for a post-market earnings report, and we’ll be interested in tracking the activity in APDN at least through the remainder of this short week, and possibly into the upcoming short week as well.


Extended Watchlist:
ALSK, ATOS, CAG, CLNT, HMNY, WATT,

Blue Horseshoe Stocks: Cannabis Commentary & More

NeoPhotonics Corp. NPTN

We’re always bargain hunting for stocks that have been recently beaten back to what appear to be unsustainably low levels, and we’re observing one heck of a double bottom setup on NPTN at the present time.

Twice now the stock has touched and rebounded off of the mid-$4 range, with the annual low coming in at 4.56. We’re going to want to place NPTN on watch in sessions to come and look for the stock to establish higher levels of support.



Valeant Pharmaceuticals International, Inc. VRX

It’s been awhile since we had a look at VRX, and as it turns out, this is another stock that looks ready to start a trend off of a recent relative low.

VRX is gapping up considerably into the $14-range this morning on the heels of a solid earnings beat. We’re going to signal a range of options contracts to watch for some possible dip-and-rip activity. This is just the type of setup we routinely look for, and we’ll be tracking the VRX Weekly $13-14 Calls for the remainder of the week.



Cannabis Commentary

It has been a slow year in general for many domestic cannabis stocks, due, at least in part, to a DOJ led by outspoken marijuana opponent Jeff Sessions. It has created an environment of uncertainty pertaining to the federal government’s likelihood of creating problems for marijuana businesses, even in states where voters have officially spoken and legalized the plant. The marijuana movement is here to stay, but at present, is dealing with this roadblock of sorts.

That doesn’t mean our interest in the sector has diminished. In fact, we’re as exuberant about the future of the cannabis industry as we ever were. North of the Border, Canadians will enact a nationwide end to prohibition just 8 months from now.

The World Anti-Doping Agency, which was formed by the International Olympic Committee to police the use of performance enhancing drugs in athletics, also recently removed Cannabidiol (CBD) from its list of banned substances, opening up a huge market for the hemp-derived product.

Here are just a few of the cannabis plays that we track on a regular basis, and will continue to do so as we head into 2018, which we feel is going to be a big year for the industry and all of its subsectors. Maybe the biggest one yet!

MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, CBIS, XXII,


Extended Watchlist:
TXMD, EVEP, DXTR, COLL, CRC